Cindy Motz
Stock Analyst at Goldman Sachs
(0.31)
# 4,077
Out of 4,761 analysts
21
Total ratings
17.65%
Success rate
-17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLN MultiPlan | Maintains: Neutral | $220 → $82 | $29.28 | +180.05% | 2 | Nov 16, 2022 | |
| HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $108.60 | -29.10% | 3 | Oct 21, 2022 | |
| ACCD Accolade | Maintains: Buy | $15 → $16 | $6.93 | +130.88% | 5 | Oct 7, 2022 | |
| HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $5.23 | +244.17% | 5 | Aug 10, 2022 | |
| DOCS Doximity | Maintains: Buy | $53 → $46 | $72.37 | -36.44% | 3 | Aug 8, 2022 | |
| TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $11.51 | +212.77% | 3 | Jul 28, 2022 |
MultiPlan
Nov 16, 2022
Maintains: Neutral
Price Target: $220 → $82
Current: $29.28
Upside: +180.05%
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $108.60
Upside: -29.10%
Accolade
Oct 7, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $6.93
Upside: +130.88%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $5.23
Upside: +244.17%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $72.37
Upside: -36.44%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $11.51
Upside: +212.77%